Literature DB >> 27860538

Loss of TGF-β signaling drives cSCC from skin stem cells - More evidence.

Aidan M Rose1, Owen J Sansom2, Gareth J Inman1.   

Abstract

Keywords:  TGF-β; TGF-β receptors; mutation; skin; squamous cell carcinoma; stem cells

Mesh：

Substances：

Year:  2016        PMID： 27860538      PMCID： PMC5351926          DOI： 10.1080/15384101.2016.1259892

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1.

Authors:  David R Goudie; Mariella D'Alessandro; Barry Merriman; Hane Lee; Ildikó Szeverényi; Stuart Avery; Brian D O'Connor; Stanley F Nelson; Stephanie E Coats; Arlene Stewart; Lesley Christie; Gabriella Pichert; Jean Friedel; Ian Hayes; Nigel Burrows; Sean Whittaker; Anne-Marie Gerdes; Sigurd Broesby-Olsen; Malcolm A Ferguson-Smith; Chandra Verma; Declan P Lunny; Bruno Reversade; E Birgitte Lane
Journal:  Nat Genet       Date:  2011-02-27       Impact factor: 38.330

2.  Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.

Authors:  Jean Philippe Arnault; Christine Mateus; Bernard Escudier; Gorana Tomasic; Janine Wechsler; Emilie Hollville; Jean-Charles Soria; David Malka; Alain Sarasin; Magalie Larcher; Jocelyne André; Nyam Kamsu-Kom; Lise Boussemart; Ludovic Lacroix; Alain Spatz; Alexander M Eggermont; Sabine Druillennec; Stephan Vagner; Alain Eychène; Nicolas Dumaz; Caroline Robert
Journal:  Clin Cancer Res       Date:  2011-11-17       Impact factor: 12.531

3.  Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.

Authors:  Pritesh S Karia; Anokhi Jambusaria-Pahlajani; David P Harrington; George F Murphy; Abrar A Qureshi; Chrysalyne D Schmults
Journal:  J Clin Oncol       Date:  2013-12-23       Impact factor: 44.544

4.  Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma.

Authors:  John C Morris; Antoinette R Tan; Thomas E Olencki; Geoffrey I Shapiro; Bruce J Dezube; Michael Reiss; Frank J Hsu; Jay A Berzofsky; Donald P Lawrence
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

5.  NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis.

Authors:  Charlotte M Proby; Catherine A Harwood; Irene M Leigh; Andrew P South; Karin J Purdie; Stephen A Watt; Sam Haldenby; Nicoline den Breems; Michelle Dimon; Sarah T Arron; Michael J Kluk; Jon C Aster; Angela McHugh; Dylan J Xue; Jasbani Hs Dayal; Kim S Robinson; Sm Hasan Rizvi
Journal:  J Invest Dermatol       Date:  2014-03-24       Impact factor: 8.551

6.  Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.

Authors:  Patrizia Cammareri; Aidan M Rose; David F Vincent; Jun Wang; Ai Nagano; Silvana Libertini; Rachel A Ridgway; Dimitris Athineos; Philip J Coates; Angela McHugh; Celine Pourreyron; Jasbani H S Dayal; Jonas Larsson; Simone Weidlich; Lindsay C Spender; Gopal P Sapkota; Karin J Purdie; Charlotte M Proby; Catherine A Harwood; Irene M Leigh; Hans Clevers; Nick Barker; Stefan Karlsson; Catrin Pritchard; Richard Marais; Claude Chelala; Andrew P South; Owen J Sansom; Gareth J Inman
Journal:  Nat Commun       Date:  2016-08-25       Impact factor: 14.919
  6 in total
  5 in total

Review 1.  Skin immunity and its dysregulation in psoriasis.

Authors:  Caterina Lanna; Mara Mancini; Roberta Gaziano; Maria Vittoria Cannizzaro; Marco Galluzzo; Marina Talamonti; Valentina Rovella; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Ying Wang; Yufang Shi; Elena Campione; Luca Bianchi
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

2.  Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous Carcinoma.

Authors:  Audris Chiang; Caroline Z Tan; François Kuonen; Luqman M Hodgkinson; Felicia Chiang; Raymond J Cho; Andrew P South; Jean Y Tang; Anne Lynn S Chang; Kerri E Rieger; Anthony E Oro; Kavita Y Sarin
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

3.  TGFβ1 regulates HRas-mediated activation of IRE1α through the PERK-RPAP2 axis in keratinocytes.

Authors:  Saie Mogre; Nicholas Blazanin; Hailey Walsh; Jack Ibinson; Chase Minnich; Chih-Chi Andrew Hu; Adam B Glick
Journal:  Mol Carcinog       Date:  2022-08-17       Impact factor: 5.139

Review 4.  Update on the etiopathogenesis of psoriasis (Review).

Authors:  Daciana Elena Branisteanu; Catalina Cojocaru; Roxana Diaconu; Elena Andrese Porumb; Anisia Iuliana Alexa; Alin Codrut Nicolescu; Ilarie Brihan; Camelia Margareta Bogdanici; George Branisteanu; Andreea Dimitriu; Mihail Zemba; Nicoleta Anton; Mihaela Paula Toader; Adrian Grechin; Daniel Constantin Branisteanu
Journal:  Exp Ther Med       Date:  2022-01-05       Impact factor: 2.447

5.  Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial.

Authors:  Luis Paz-Ares; Tae Min Kim; David Vicente; Enriqueta Felip; Dae Ho Lee; Ki Hyeong Lee; Chia-Chi Lin; Maria Jose Flor; Massimo Di Nicola; Rosa Maria Alvarez; Isabelle Dussault; Christoph Helwig; Laureen S Ojalvo; James L Gulley; Byoung Chul Cho
Journal:  J Thorac Oncol       Date:  2020-03-13       Impact factor: 15.609
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.